About this Research Topic
Gastrointestinal (GI) cancers are among the most common cancer types affecting millions worldwide with a poor survival rate and prognosis. GI cancers are within the most frequent malignancy, with almost 150,000 new cases in 2020. On one hand, a large number of researches are focused on the diagnosis of GI cancers and more specifically, new diagnostic approaches in upper and lower gastrointestinal tract cancers. On the other hand, in the last 10 years, several papers had been published about the possible therapeutic targets highlighting precision and personalized medicine.
The goal of this Research Topic is to provide a discussion regarding new molecular targets for diagnostics, individualized treatment for better survival. We welcome Original Research, Reviews, Systematic Reviews and Mini-Reviews. We particularly welcome research regarding emerging therapeutic targets in GI Cancers and precision and individualized medicine of GI cancers.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
The goal of this Research Topic is to provide a discussion regarding new molecular targets for diagnostics, individualized treatment for better survival. We welcome Original Research, Reviews, Systematic Reviews and Mini-Reviews. We particularly welcome research regarding emerging therapeutic targets in GI Cancers and precision and individualized medicine of GI cancers.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords: Gastrointestinal cancer, novel molecular biomarkers, WGS and WES, individualized therapy, precision medicine
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
